Vaccine Insights Volume 4 Issue 9

VACCINE INSIGHTS

Volume 4 Issue 9

Vaccine Insights Volume 4 Issue 9

Download PDF

Featuring

Issue Spotlight: How close are we to meeting the 100 days target to produce a vaccine?
Vaccine Clinical Update focus: November Update
Other articles

How close are we to meeting the 100 days target to produce a vaccine?

Review

Inclusive innovation responses to epidemic challenges: a multi-case study of MERS, Zika and Ebola outbreaks

Inclusive innovation responses to epidemic challenges: a multi-case study of MERS, Zika and Ebola outbreaks

J Feddema, S Ward, R Terzopoulos et al.

24 November 2025

Commentary

Preparedness to production: a Canadian perspective on building industrial capacity for health emergency readiness

Preparedness to production: a Canadian perspective on building industrial capacity for health emergency readiness

T Caminiti, A Mahdi, S Raduy et al.

9 December 2025

Preparing for the 100 days mission: end-to-end transformation for emerging infectious disease preparedness

Preparing for the 100 days mission: end-to-end transformation for emerging infectious disease preparedness

Hamilton Bennett, Alan Embry

8 December 2025

Viewpoint

Keystones of regulatory preparedness in pandemic vaccine development

Keystones of regulatory preparedness in pandemic vaccine development

Isabelle Bekeredjian-Ding

4 November 2025

Interview

A career in containment: insights from the epicenter of WHO’s COVID-19 response

A career in containment: insights from the epicenter of WHO’s COVID-19 response

Maria Van Kerkhove

8 December 2025

November Update

Commentary

The new era of vaccines: scientific challenges and their regulatory needs

The new era of vaccines: scientific challenges and their regulatory needs

L Gabriele, C Mann, L Van der Pol et al.

3 December 2025

Interview

In the making: lessons from 50 years in vaccine development

In the making: lessons from 50 years in vaccine development

5 December 2025

Journal articles

Industry Insights

Industry Insights: Multiomics, mucosal immunity, and mRNA vaccine benefits

Industry Insights: Multiomics, mucosal immunity, and mRNA vaccine benefits

Charlotte Barker

15 December 2025

}